Table 1 Baseline characteristics*.

From: Recurrence after postoperative intravesical instillation therapy in Hunner type interstitial cystitis

 

Full analysis set

Per-protocol set

Control group (N = 69)

HACS group (N = 62)

P

Control group (n = 58)

HACS group (n = 51)

P

Age (yr)

62.15 ± 9.61

64.15 ± 9.92

0.024

61.98 ± 9.62

65.52 ± 8.92

0.050

Sex, n (%)

 Male

15 (21.7)

16 (25.8)

0.585

14 (24.1)

12 (23.5)

0.941

 Female

54 (78.3)

46 (74.2)

 

44 (75.9)

39 (76.5)

 

BMI (kg/m2)

23.19 ± 2.81

23.44 ± 2.65

0.569

23.04 ± 2.79

23.46 ± 2.58

0.315

O’Leary–Sant Interstitial Cystitis questionnaire

 Symptom index

16.07 ± 3.25

15.37 ± 3.98

0.482

15.93 ± 3.22

15.55 ± 3.98

0.988

 Problem index

13.66 ± 2.47

13.42 ± 3.14

0.994

13.44 ± 2.56

13.51 ± 3.00

0.620

Pelvic pain and urgency/frequency

 Symptom score

15.53 ± 3.11

14.05 ± 3.86

0.044

15.21 ± 2.98

14.14 ± 3.88

0.109

 Bothersome score

7.83 ± 1.84

7.18 ± 2.35

0.287

7.77 ± 1.9

7.27 ± 2.27

0.564

Pain for VAS

6.97 ± 1.86

7.03 ± 2.10

0.780

6.96 ± 1.78

7.31 ± 2.01

0.259

Voiding diary

 Daytime frequency

14.11 ± 7.64

13.88 ± 6.31

0.740

13.56 ± 7.36

13.86 ± 6.54

0.536

 Nocturia

3.77 ± 2.50

3.16 ± 2.02

0.128

3.74 ± 2.62

3.11 ± 1.88

0.222

 Urgency

12.99 ± 12.05

10.3 ± 8.75

0.377

12.5 ± 11.66

10.41 ± 8.89

0.570

  1. BMI body mass index; HACS hyaluronic acid and chondroitin sulfate; VAS visual analog scale.
  2. *Values are expressed as mean ± standard deviation.